InMode Ltd. (INMD)Healthcare | Medical Devices | Yokne'am, Israel | NasdaqGS
14.85 USD
+0.01
(0.067%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 14.96 +0.11 (0.741%) ⇧ (Aug. 28, 2026, 7:46 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:36 a.m. EDT
The investment case for InMode is currently bifurcated between a distressed value narrative and a speculative takeover catalyst. Fundamentally, the company presents a classic value trap: while the balance sheet is pristine with massive cash reserves and negligible debt, the multi-year price trajectory tells a different story. The stock has suffered two consecutive years of decline, dropping nearly 60% from its 2022 peak, which suggests the market has permanently repriced the business quality despite recent quarterly earnings beats. The lack of a dividend policy eliminates income appeal entirely. However, the short-term outlook is being propped up by external events rather than internal momentum. The recent unsolicited takeover proposal from Steel Partners has injected immediate volatility and created a speculative floor, evidenced by the heavy call option open interest at strikes significantly above the current price. This options flow signals that traders are positioning for a binary event—a deal closing or a sharp re-rating—rather than a steady fundamental recovery. Without a definitive resolution to the takeover talks or a reversal of the multi-year downtrend, the stock remains a high-risk speculative vehicle rather than a compelling long-term compounder. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.080033 |
| AutoARIMA | 0.080048 |
| MSTL | 0.080794 |
| AutoTheta | 0.080860 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 12.57 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.053 |
| Excess Kurtosis | -1.22 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.707 |
| Revenue per Share | 6.022 |
| Market Cap | 854,531,008 |
| Trailing P/E | 12.27 |
| Forward P/E | 10.82 |
| Beta | 1.87 |
| Profit Margins | 20.69% |
| Website | https://www.inmodemd.com |
As of Aug. 22, 2026, 3:36 a.m. EDT: Speculator positioning is heavily skewed toward out-of-the-money calls, particularly for the February 2027 expiration where open interest at strikes 20 and 22 exceeds 1,000 contracts. This indicates a speculative bet on a significant upside move, likely driven by the recent takeover proposal news. Conversely, put activity is minimal and concentrated deep in-the-money, suggesting limited hedging demand compared to the aggressive call buying.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.030534387 |
| Address1 | Tavor Building |
| Address2 | Sha’ar Yokneam PO Box 533 |
| All Time High | 99.27 |
| All Time Low | 6.53 |
| Ask | 16.5 |
| Ask Size | 1 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 397,600 |
| Average Daily Volume3 Month | 610,960 |
| Average Volume | 610,960 |
| Average Volume10Days | 397,600 |
| Beta | 1.867 |
| Bid | 10.75 |
| Bid Size | 2 |
| Book Value | 10.681 |
| City | Yokne'am |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 14.85 |
| Current Ratio | 8.183 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 14.94 |
| Day Low | 14.831 |
| Debt To Equity | 0.707 |
| Display Name | InMode |
| Earnings Call Timestamp End | 1,778,070,600 |
| Earnings Call Timestamp Start | 1,778,070,600 |
| Earnings Growth | -0.31 |
| Earnings Quarterly Growth | -0.362 |
| Earnings Timestamp | 1,785,933,000 |
| Earnings Timestamp End | 1,793,795,400 |
| Earnings Timestamp Start | 1,793,795,400 |
| Ebitda | 71,147,000 |
| Ebitda Margins | 0.18992001 |
| Enterprise To Ebitda | 5.314 |
| Enterprise To Revenue | 1.009 |
| Enterprise Value | 378,045,536 |
| Eps Current Year | 1.296 |
| Eps Forward | 1.372 |
| Eps Trailing Twelve Months | 1.21 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 14.956 |
| Fifty Day Average Change | -0.10599995 |
| Fifty Day Average Change Percent | -0.007087453 |
| Fifty Two Week Change Percent | 3.0534387 |
| Fifty Two Week High | 16.74 |
| Fifty Two Week High Change | -1.8899994 |
| Fifty Two Week High Change Percent | -0.11290319 |
| Fifty Two Week Low | 12.72 |
| Fifty Two Week Low Change | 2.13 |
| Fifty Two Week Low Change Percent | 0.16745284 |
| Fifty Two Week Range | 12.72 - 16.74 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,565,271,000,000 |
| Float Shares | 49,120,390 |
| Forward Eps | 1.372 |
| Forward P E | 10.823616 |
| Free Cashflow | 47,395,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 660 |
| Fullday Change | 0.0100002 |
| Fullday Change Percent | 0.067387 |
| Fullday Price | 14.96 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.76524 |
| Gross Profits | 286,676,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13161999 |
| Held Percent Institutions | 0.55955005 |
| Implied Shares Outstanding | 57,544,172 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,633,046,400 |
| Last Split Factor | 2:1 |
| Long Business Summary | InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel. |
| Long Name | InMode Ltd. |
| Market | us_market |
| Market Cap | 854,531,008 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_100060854 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 77,514,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 853,955,512 |
| Number Of Analyst Opinions | 3 |
| Open | 14.88 |
| Operating Cashflow | 83,578,000 |
| Operating Margins | 0.12823 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.83 |
| Phone | 972 4 909 6313 |
| Post Market Change | 0.10999966 |
| Post Market Change Percent | 0.7407384 |
| Post Market Price | 14.96 |
| Post Market Time | 1,787,960,816 |
| Previous Close | 14.84 |
| Price Eps Current Year | 11.458334 |
| Price Hint | 2 |
| Price To Book | 1.3903193 |
| Price To Sales Trailing12 Months | 2.2810304 |
| Profit Margins | 0.20691 |
| Quick Ratio | 6.869 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | 0.0100002 |
| Regular Market Change Percent | 0.067387 |
| Regular Market Day High | 14.94 |
| Regular Market Day Low | 14.831 |
| Regular Market Day Range | 14.831 - 14.94 |
| Regular Market Open | 14.88 |
| Regular Market Previous Close | 14.84 |
| Regular Market Price | 14.85 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 456,640 |
| Return On Assets | 0.06165 |
| Return On Equity | 0.12328 |
| Revenue Growth | -0.0 |
| Revenue Per Share | 6.022 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 57,544,172 |
| Shares Percent Shares Out | 0.0423 |
| Shares Short | 2,431,597 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,991,360 |
| Short Name | InMode Ltd. |
| Short Percent Of Float | 0.0479 |
| Short Ratio | 4.75 |
| Source Interval | 15 |
| Symbol | INMD |
| Target High Price | 17.0 |
| Target Low Price | 15.0 |
| Target Mean Price | 16.16667 |
| Target Median Price | 16.5 |
| Total Cash | 501,115,008 |
| Total Cash Per Share | 8.507 |
| Total Debt | 4,451,000 |
| Total Revenue | 374,624,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.21 |
| Trailing P E | 12.272727 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.355425 |
| Two Hundred Day Average Change | 0.4945755 |
| Two Hundred Day Average Change Percent | 0.034452166 |
| Type Disp | Equity |
| Volume | 456,640 |
| Website | https://www.inmodemd.com |
| Zip | 2,069,206 |